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The current methods for tumor induction in breast cancer research animal models are time-consuming, 
hazardous, expensive, sometimes irreproducible and inconvenient. We successfully developed a new, 
simple and cost-effective method in developing solid mammary gland tumor in female Sprague-Dawley 
rat using LA7 rat mammary tumor cells. Tumors developed in 7- 8 weeks old rats within 6 to 8 days of 
subcutaneous injection of LA7 cells into the mammary gland pad. Tumor size increased exponentially 
for four weeks. Histopathology examination confirmed that the induced tumors were adenocarcinomas. 
Evaluation of blood enzymes showed significantly higher (P < 0.005) serum alkaline phosphatase (ALP) 
and lactate dehydrogenase (LDH) in tumor-bearing than in normal rats. This LA7 cell-induced rat 
mammary gland tumor model may be useful for studies in breast cancer drug or nutraceutical research 
and development. 
 





Due to the importance of carcinogenicity experiment in 
cancer research studies, many attempts have been 
devoted to the development of new methods for trans-
duction and evolution of tumor in animals (Salami and 
Karami, 2003). The induction of mammary gland tumors 
issue in animal has been a controversial and much 
disputed subject in cancer research. Immunodeficient and 
nude mice are normally used for transplantation and 
xenografts in cytotoxicity studies of various chemotherapy 
drugs in malignancies (Kim et al., 2006); but they are 
inconvenient since they are expensive, need to be kept 
under sterile conditions and have a short life-span. 
Recently, there has been an increasing interest in 
carcinogenic chemicals such as 7,12-dimethylbenz(a) 
anthracene (DMBA) and N-methyl-N-nitrosourea (NMU) 
to induce mammary carcinoma in rat models for the study 
of human breast cancers (salami and karami, 2003).  
However, the main problems with these applications are 
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However, far too little attention has been paid to rat than 
mouse and only limited types of transgenic rats have 
been developed for carcinogenic study (Jacob et al., 
2004). In addition, the benefit of rat animal model is its 
simplicity and different induction methods, transplantation 
ability and resemblance to human breast cancer in their 
hormone sensitivity and histology. There is no other 
animal tumor comparable to these models because of the 
similarity in the function and structure of certain rat 
mammary tumors to hormone-sensitive human breast 
cancer (Young and Hallowers, 1973).   
Mammary gland LA7 cells were isolated in 1979 from a 
DMBA-induced mammary adenocarcinoma in rats 
(Dulbecco et al., 1979; Bennet et al., 1978). The self-
renewal properties of stem cell have showed that these 
cells are able to differentiate into all kinds of mammary 
gland cell lineages and develop heterogeneous tumors in 
(NOD)-SCID mice at a single-cell level (Zucchi et al., 
2007). Characterization of a single-cell with the potential 
of tumor-induction may contribute to the improvement of 
a suitable therapy.  
The purpose of this paper is to design an easy, cost-
effective, rapid induction, and readily applied  rat  mammary  








MATERIALS AND METHODS 
 
Animals and management 
 
The experimental procedure was approved by the Institutional 
Animal Care and Use Committee (IAUC) of Faculty of Veterinary 
Medicine at University Putra Malaysia (UPM) and research was 
conducted according to the guidelines for the care and use of 
laboratory animals of UPM. Twenty virgin female Sprague-Dawley 
(SD) rats (6- 8weeks old), with weigh of 180 - 200 g were 
purchased from Sapphire Enterprise, Malaysia. The animals were 
divided into two groups; ten animals as tumor-bearing and ten as 
normal control group. Animals were housed two rats per plastic 
cages and allowed to acclimate in standard conditions (under a 12 
h light/dark cycle) for one week. The rats were given 






Rat mammary gland tumor cell line, LA7 (ATCC No CRL2283) was 
kindly offered by Dr Teo Guan Young (Institute Bioscience, UPM). 
Cells were maintained at 37°C in a humidified atmosphere of 5% 
CO2 in Dulbecco’s modified eagle’s medium (DMEM) supplemented 
with 10% fetal bovine serum (FBS), 100 µg/ml streptomycin and 
100 IU/ml penicillin.  
 
 
Cell preparation  
 
When the cells were 90% confluent, the medium was removed and 
the cells washed with PBS to remove dead and undetached cells. 
Low amount of trypsin-EDTA was added to detach cells. Cells were 
obtained immediately by centrifugation at 100 g for 10 min at 4°C, 
washed twice with PBS and dispersed. For viability detection, the 
cells were stained with trypan blue and counted using a 
hemocytometer. Cells were eventually suspended in 300 l of PBS. 
All harvested cells were used within one hour of preparation. 
 
 
Mammary tumor induction  
 
Because of ease of handling and speed of use, the rats were 
anesthetized by intraperitoneal injections of a mixture of ketamine-
HCl and xylazine (150 and 10 mg/kg, respectively). The animals 
were positioned securely in a stereotactic frame with the top flat 
surface of the cranium parallel to the ground. The injection site was 
properly cleaned and sterilized with ethanol. The cell suspension (6 
× 106 cells in 300 µl PBS) was drawn into 1-cc (1-ml) TB syringes 
without needles to minimize damage, lysis and death to the cells. 
The cell suspension was inoculated subcutaneously into the 
mammary fat pad (right flank) of the SD rats using a TB syringe with 
#26 gauge needle. The needle was positioned 2 mm posterior and 
2.5 mm lateral to the mammary gland, inserted through the skin and 
then lowered 5 mm into the mammary fat pad. The 300 µl cell 
suspension was injected slowly over five minutes. The areas 
surrounding the injection site were washed with a generous amount 
of warm PBS to dissipate any cells that may have spilled or leaked. 
The beds of rats were supported with suitable heat lamp because 
animals may lose body heat during the procedure. The temperature, 
breathing and heart rates of animals were monitored closely. To 










The latency period and tumor incidence was determined as tumor 
growth landmarks (Riveraa et al., 1994). All animals were monitored 
for mammary tumor development. Tumor diameters and animal 
weight were measured every week. The tumor mass was measured 
horizontally and vertically using a digital caliper. Volume of tumor 
(V) was calculated by the formula determined by Carlsson: V= 
(ab2)/2, where ‘a’ and ‘b’ is the longest and shortest diameters of 





The tumor mass in rat breast area was confirmed by radiographs 
using a soft X-ray instrument (Shimadzu, Japan). Prior to imaging, 
animals were shaved and anesthetized as described earlier. The 
rats were exposed to the X-ray at 44 kV, for 2.5 milliseconds.  
 
 
Blood test (biochemical analysis) 
 
Blood samples were collected from the healthy and tumor-bearing 
rats by cardiac puncture using #23 gauge needles before and after 
development of the tumor. After collection, the samples were 
allowed to clot at room temperature and centrifuged at 300 g for 10 
min. Serum were then separated and analyzed for lactate dehydro-
genase (LDH), alkaline phosphatase (ALP), alanine aminotransferase 
(ALT) and glutamate dehydrogenase (GGT) by a chemistry analyzer 
(Hitachi 902, Japan) using standard diagnostic kits (Roche).  
 
 
Histological analysis  
 
At the end of the study, the tumor masses, lungs and livers of rats 
were removed and examined for tissue abnormalities. Sample of 
tissues were fixed immediately in 10% formalin overnight, embedded in 






The data obtained were subjected to statistical analysis. The 
differences in mean values among the two groups were expressed 
as mean ± standard deviation. All the calculations were performed 







Mammary tumors were observed as early as 7 to 10 days 
after LA7 cell injections, which indicated that the cells 
have strong tumorigenicity properties. The results of soft 
X-ray images of tumor bearing rats are presented in 
Figure 1. The tumor was soft, rubbery and as it grew, 
became irregular and lobulated (Figure 2). Tumors adhered 
more to the skin than the body wall (Figure 3).  
Tumors in the LA7 cell-injected group grew rapidly and 
reached an average volume of 1821.13 mm3 by  the  30th  






Figure 1. Soft X-ray images from two rats bearing breast tumor obtained after one week injection of cancer cells. Total 6 × 106 






Figure 2. Mammary tumors were observed as early as 7 to 10 days after LA7 cell injections in 80% of rats (a). Tumors in the 






Figure 3. Solid tumor growth in LA7 cell injected rats. The tumor was more adhesive to the skin than to the body wall 
showing invasiveness of tumor into lung area. 










































Figure 4. Effect of 300 l of LA7 cell (total 6 × 106 cells) on tumor volume. After the cancer cell administration, 
the sizes of tumor were monitored by measuring externally at two dimensions. The tumor volume was 
calculated by multiplying the length of the tumor with the square of the width and dividing the product by two. 





























Figure 5. Effect of 300 l of LA7 cell (total 6 × 106 cells) on body weight changes of injected group. Data are 
means of results for six rats in control group and eight rats in injected group. Statistical significant are expressed 




day (Figure 4). The animal weight increased during the 
study; however, no significant difference was found 
between healthy and carcinogenic rats (P > 0.05) (Figure 
5). The rate of mammary tumor developed in these rats 
was 80%.  
Pathologic study of tumors 
 
The histopathological features of tumors developed in 
rats with mammary gland tumors were reactive lymphatic 
follicular  hyperplasia,  typical  appearance  of  neoplastic  
















cell with invasive features, high mitotic activity and necrosis 
consistent with adenocarcinomas (Figures 6-9). In 
adenocarcinoma, malignant tumors are derived glandular 
epithelium and have an adenomatous appearance. The 
epithelium cells are arranged in gland-like structures 
surrounding a lumen. Nucleoli are often prominent and 
mitotic figures are abundant (Young and Hallowes, 1973). 
The liver sections of rats in all group represented normal 
tissue and the lung section of rats were free of neoplastic 
involvement (data not shown). 
 
 
Blood test analysis 
 
The results obtained from the biochemical assays are 
shown in Table 1. Data from this table shows that there 
was significant increase in serum ALP concentration in 
the tumor-bearing rat from the first to the last week of the 
experiment (P < 0.05). In our study, the serum ALP 
concentration in the tumor-bearing rat decreased over 
week 4, which remained significantly higher than the 
normal group. Although serum ALT concentrations were 
observed to be high in tumor-bearing rats, these values 
returned to normal levels by the end of the study. During 
experiment period, the tumor-bearing rats showed 
significant increase in serum lactate dehydrogenase (LDH) 
concentrations when compared to the normal group. In 
the final week only, two of LA7 cell-injected rats showed 






This study set out with the aim of assessing the importance 
of carcinogenicity in induced  rat  mammary  gland  tumor  
















Table 1. Serum enzyme and total protein levels in control and carcinogenesis rats. 
 
Group Week ALT (U/L) ALP (U/L) LDH (U/L) 
Normal  49±2.53 66a±26.50 584a±117.25 
Cancer 1 73.01±42.1 262.13b±106.85 2208.37b±657.75 
 4 52.2±14.12 226.13b±59 3202.88b±1102.32 
 
All values are expressed as mean ± standard deviation.a,bMeans with the different superscripts are significantly different; p 




as a model for breast cancer studies. Although, there 
have been different methods for tumor induction, such as 
chemical carcinogens (Huggins et al., 1961) and ionizing 
radiation (Gross et al., 1988), they are time-consuming 
and hazardous. In this study, we used the rat mammary 
tumor cell, LA7, to induce mammary tumors in right flank 
of rats to produce malignant tumors. Using this method, 
the mammary gland tumor developed at the site of 
injection within 7 to 10 days. Kim et al. (2006) showed the 
tumorigenicity of the rat kidney epithelial cells (1 × 107 
cells/200 µl) harboring k-ras gene (RK3E-ras) in male SD 
rats. All of the SD rats injected with RK3E-ras cells 
developed tumor mass at the inoculated site. In our 
study, the rate of tumorigenicity of LA-7 cells (6 × 106 
cells/300 µl) in these rats was 80%. Other advantages of 
this tumor induction method are the ease of inoculation 
method, continuity and reproducibility of tumor growth, 
safe and economical. The model may be used for breast 
cancer studies, to include determination of the processes 





Another important advantage of this model is that the 
tumor rarely developed metastasis or expressed cell 
surface molecules which are different from the cells of the 
origin tissue (Jacob et al., 2004). In our study, the body 
weights of the rats did not show significant difference 
between normal and tumor-bearing rats, suggesting that 
this method did not produce side-effects that could cause 
weight loss, while in the study of Perumal et al. (2005a) 
and Padmavathi et al. (2006), although initially, there was 
no significant change in the body weight of the control 
and experimental rats, but finally, there was a significant 
(p < 0.001) decrease in the body weight of the DMBA-
induced tumor in female SD rats. The histopathological 
feature of our experimental tumor model was similar to 
human breast cancers in characteristics, particularly in 
morphological feature or cellular components. Therefore, 
this animal model is suitable for application in the study of 
breast cancers. According to Qin et al. (2007), the 
outcomes from chemically induced mammary tumor in 
rats cannot be extrapolated to the development of spon-
taneous breast cancer in human directly. 
Tumor markers are most useful for monitoring response 
to therapy and early detection of cancer. The result of this 
study showed elevated serum ALP concentration in the 
tumor-bearing rats. One study showed that serum ALP 
concentration increased significantly in cancer patients 
with metastasis (Mishra et al., 2004). In our rats, there 
was no evidence of metastasis, suggesting that the 
increased serum ALP may in fact be due to the primary 
tumor. Liver metastasis (Wang et al., 2006) and heap-
totoxicity (Lynch et al., 2005) also can be determined by 
changes in serum ALT. However, by the lack of change 
in serum ALT, it seems that neither hepatotoxicity nor 
liver metastasis occurred in our tumor-bearing rats. 
Serum LDH concentrations often increased significantly 
in cancer patients with endometrial and ovarian cyst 
adenocarcinomas but not in patients with breast cancers 
(Koukourakis et al., 2008). According to Perumal et al. 
(2005b), the elevated activity of LDH may be due to over-
production by tumor cells, or it may be due to the release 
of isoenzymes from destroyed tissues. Our results are 
also consistent with the above reports. The significant 
high (P < 0.05) serum LDH concentrations observed in 
this study were similar to those in human cancer patients 
with endometrial adenocarcinoma, ovarian cyst adeno-
carcinomas and breast cancers. However, it was suggested 
that the serum LDH concentration is nonspecific for the 
diagnosis of metastasis (Mishra et al., 2004). Some 
studies showed correlations between serum GGT 
concentration and malignant neoplasm such as cancers 
of the digestive, respiratory, female genital, lymphoid and 
hematopoietic organs (Strasak et al., 2008),   
However, our findings showed that the serum GGT 
concentrations were not significantly different in normal 
and tumor-bearing rats suggesting that this serum 
parameter is not a good biomarker for rat mammary 
gland tumors. In contrast, there are studies (Sani et al., 
2004)   that   reported   serum   GGT  significant  increase  in  




women with breast malignant neoplasm, while others 
reported no significant increase in GGT levels in cancer 
patients without metastasis (Durham et al., 1997). It is 
possible that either this enzyme is not related to 
mammary tumor development or maintenance or four 
weeks of tumor development were not sufficient to cause 
changes in these serum parameters. Longer studies are 
recommended to determine the importance of these 
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